Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE 2. REPORT TYPE
5f. WORK UNIT NUMBER
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER
The Geneva Foundation Tacoma, WA 98402
INTRODUCTION
The developmental processes for bone tissue is complex and involves several tightly regulated gene expression patterns of bone associated proteins. The expression of these genes and proteins are regulated in a temporal manner both in vivo and in vitro and has previously been studied in both these systems. The process of osteoblast differentiation can be subdivided into 3 stages, namely, proliferation, extracellular matrix synthesis and maturation and, lastly, mineralization.
Each stage is characterized by the expression of distinctive bone markers. It has been demonstrated by Stein and Lian [1] that during bone formation the expression of extracellular matrix genes (type I collagen, fibronectin, transforming growth factor-131), cell cycle or growth-related genes (histone, c-fos, c-myc) increased initially, followed by genes associated with mineralization, such as osteocalcin, osteopontin and bone sialoprotein. In addition, osteoblastproduced circulating cytokines and growth factors also influence the differentiation process.
We proposed to determine early in vitro gene expression changes in osteoblasts when infected with multidrug resistant Gram negative bacteria. An in vitro 3 dimensional (3-D) model of primary human osteoblasts on a collagen scaffold was to be developed for the study. The 3-D osteoblast cultures would then be infected with clinical isolates of multidrug resistant Acinetobacter baumannii (AB), Klebsiella pneumonia (KP) and Pseudomonas aeruginosa (PA). Post infection, early osteoblast differentiation and maturation processes would be determined in a temporal manner by gene expression. Utilizing this model, the therapeutic effects of antimicrobial peptides on osteoblasts infected with these three bacteria would be determined.
BODY Milestone 1: In vitro infection studies
A collagen scaffold model with primary human osteoblasts was developed in the laboratory following modifications of Shen et al [2] . In the second year, work began with primary osteoblasts utilizing the established 3-D collagen scaffold model. In order to relate to war trauma, primary osteoblasts from healthy male subjects between the ages of 18-45 years were purchased from commercial sources (Lonza and Promocell Inc). In the third year, work was completed on gene array studies (n=3). Utilizing this model, the peptide KSL-W was tested against all 3 pathogens for bactericidal activities.
Accomplished work for Milestone 1:
Establishment of a 3-D osteoblast model in vitro
Initial work was performed with human osteoblast cell line SaOs2. Osteoblasts were seeded on collagen scaffold, and the quantity of ALP in osteoblasts increased over time [Fig 6] . From these studies, it was determined that the cells in the scaffolds were differentiating over time. A time point between 11-14 days was selected for infections as it showed increasing ALP, collagen 1 and osteocalcin expression in cells, indicating differentiation and matrix maturation of osteoblasts. Once the scaffold model was established, infection with bacteria was performed.
In the past, others have developed 3-D scaffolds with osteoblasts in vitro for bone regeneration [3] , [4] , [5] . Recently, investigators have reported infections utilizing a collagen-osteoblast model [6] .
Infection of primary osteoblasts in the 3-D model (invasion assays)
Clinical isolates of MDR Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae were obtained from WRAMC. For infections, bacterial cultures from an LB agar plate streaked overnight were used. Bacteria were re-suspended in saline. OD's and appropriate CFUs were estimated for infections. As all three species of bacteria have been reported to invade epithelial and other cells [7, 8, 9] we investigated if these pathogens could also invade osteoblasts. Primary human osteoblasts seeded on scaffolds for days 11-14 were used for infections. The day before infection, media was replaced in wells with antibiotic free media. For infections, excess media was removed on sterile Kimwipe from each scaffold and moved to a 6 well plate. The appropriate number of bacteria was added onto the scaffold in a 10ul volume. Scaffolds were incubated for 2hrs at 37 0 C. After 2 hours, each scaffold was rinsed in PBS and placed in a 24 well plate with DMEM + 10% FBS and 100ug/ml polymyxin B. After 1 hour (t=0) for extracellular bacteria to be killed by polymyxin B, and at each time point, scaffolds were rinsed in PBS, and digested in 1mg/ml collagenase for 30 minutes, and cell pellets were obtained after centrifugation at 2500rpm for 2 minutes in a micro-centrifuge. At each time point, cells were lysed with deionized distilled water. Cell lysates were plated on LB agar plates and the CFUs were enumerated the following day. Supernates from each well were plated out to ensure killing of extracellular bacteria (data not shown). Invasion assays performed on osteoblasts in the collagen scaffolds indicated that all 3 species of bacteria could be detected intra-cellularly [ Fig. 7 ].
The fate of these Gram negative intracellular pathogens after the death of the osteoblast is not known.
The ability of released intracellular bacteria to re-infect new osteoblasts was investigated. In the invasion assays, to enumerate intracellular bacteria in osteoblasts, deionized water was used to release bacteria. This method, however, does not mimic the natural process of death of osteoblasts. We plated infected whole osteoblasts (not lysed) in order to look at the fate of intracellular bacteria after a more natural death of osteoblasts. Recovered bacteria were then used to re-infect new cells, thus creating a process which could reflect the clinical situation.
Monolayer SaOS2 osteoblasts were infected with AB, KP or PA. Infection proceeded for 2 hours. After 2 hours, wells were rinsed with PBS and media containing 100ug/ml of polymyxin B was added for 1 hour to kill extracellular bacteria. At 0, 24 and 72 hours post infection, infected cells were either lysed with distilled deionized water, or whole unlysed cells were plated on agar plates after the addition of Trypsin-EDTA to release cells from tissue culture plate. After overnight incubation of plates at 37 0 C the bacterial CFU's recovered from whole cells on agar plates were used to re-infect fresh SaOs2 cells. We found that that lysis of osteoblasts is a better method to recover intracellular bacteria compared to plating whole cells [ Table 1 ]. The differences in CFU may be due to less survival of bacteria in dying host cells.
Alternatively, intracellular bacteria released from dying host cells are not dispersed evenly so that the total CFUs detected may be less. Our results suggest that all three species, once released from dying osteoblasts, have the ability to re-infect healthy cells [ Table 2 ].
Cytotoxicity assays for infection of osteoblasts with Acinetobacter, Klebsiella and Pseudomonas sp
In order to determine if intracellular infections with these three pathogens would result in cytotoxicity to osteoblasts, LDH (lactate dehydrogenase) assays (Cytotox 96 cytotoxicity assay Promega, WI) were carried out on infected osteoblasts on 3-D scaffolds. This assay quantitatively measures LDH, a stable cytosolic enzyme that is released upon cell lysis. Released LDH in culture supernates is measured coupled enzymatic assay which results in the conversion of tetrazolium salt into a red formazan product.
The amount of color formed is proportional to the number of lysed cells as detected using a plate reader. Infections were performed on primary osteoblasts on 3-D scaffolds according to the manufacturer's instructions (Promega). LDH levels were determined from a standard curve. The highest toxicity was detected in osteoblasts infected with Klebsiella pneumoniae. Higher levels of osteoblast toxicity were observed at each time point after infection with all 3 bacteria compared to uninfected control [ Fig 8] . Early in the developmental sequence of the osteoblast, at one point, proliferation ceases and expression of genes related to the differentiated phenotype of osteoblasts is initiated. ALP has been found in differentiation studies with osteoblast-like cell lines in vitro [1] . In our study, when osteoblasts were infected with AB, ALP levels were down-regulated except for 24 hours post infection when induction of ALP was seen. For KP, ALP levels were down-regulated at 24 hours. PA infection resulted in the downregulation of ALP at 48 and 72 hours post infection [Table 4 ] suggesting that osteoblast differentiation/maturation was decreased at one or more time points when infected by any of these 3 wound pathogens. The implication for this observation would be that local delivery of some antibiotics has been reported to decrease the levels of ALP in healthy osteoblasts [10] . As ALP levels are also downregulated by infection, it may be important to carefully consider appropriate antibiotics to treat bone infections due to any of these 3 pathogens.
Studies on Osteoblast gene expression during infection with
Osteocalcin (BGLAP) constitutes the most abundant non-collagenous protein present in bone and an extracellular matrix protein [11] . Serum levels of osteocalcin correlate closely with bone formation [12] and, this marker has been widely used as an indicator of new bone formation in vivo [13] . Osteocalcin production correlates with the onset of bone mineralization [14] . BGLAP synthesized in the bone almost exclusively by the osteoblasts has been considered as a bone formation marker. Our data shows that osteocalcin expression was decreased at some time point for all 3 pathogens during the course of infection. The lower expression levels of both ALP and BGLAP bone markers during infection at some time point suggest that the intracellular presence of these bacteria in osteoblasts (though in small numbers) may affect the normal differentiation and maturation of osteoblasts.
A number of transcription factors are accountable for the regulation of osteoblast differentiation and function. These include Runt-related transcription factor (Runx2), Distal-less homeobox 3 (Dlx3), Distalless homeobox 5 (Dlx5), msh homeobox 2 (MSX2) and osterix (Sp7) among others, and were investigated for mRNA expression during infection.
Runx2, a cell-specific member of the Runt family of transcription factors, plays a critical role in cellular differentiation processes in osteoblasts [15] as the crucial osteogenic transcription factor expressed in early bone development. It also persists through different stages of bone formation [15, 16] Dlx5 is a bone inducing transcription factor which plays an important role in osteoblast differentiation that is expressed in the later stages [17] suggesting that Dlx5 may be involved in the maturation of the bone cell phenotype [18] . We saw that Dlx5 expression was down-regulated with AB infection, and also for PA suggesting a role in maturation delay of infected osteoblasts. Infection with KP did not alter the expression of Dlx5.
A role for Dlx3 in the up-regulation of bone-related genes to promote osteoblast differentiation has been found and shows that Dlx3 may enhance osteoblastogenesis [18] . It was also found that both Dlx3
and Dlx5 expression overlap in part during the matrix maturation stage. During osteoblast differentiation, both Dlx3 and Dlx5 act together to control the expression of osteocalcin gene.
Therefore, findings suggest that the Dlx proteins may function in a complex regulatory pathway towards osteoblast differentiation. During infection with AB, KP or PA, we saw that the expression of Dlx3 gene was also down-regulated at some time points compared to uninfected cells, again suggesting that intracellular AB, KP or PA may affect the processes of osteoblast differentiation and maturation.
The transcription factor MSX2 was significantly induced to AB infection at 24 hours. Both KP and PA infections had no response to MSX2 (data not shown). Studies have demonstrated that Msx2 promotes osteoblast differentiation and/or proliferation [19, 20] . Yet, another study by Liu et al. [21] suggested that Msx2 inhibits differentiation of osteoblast precursors and immature osteoblasts.
Twist 1 is an essential transcription factor, whose down-regulation is required for osteoblast differentiation. Studies have revealed that the role of Runx2 in osteoblast differentiation was controlled by Twist1. Twist1 is able to inhibit osteoblast differentiation without affecting RUNX2 expression [22] .
Even though infection with KP did not result in changes in Twist1 expression, its up-regulation in AB and PA infections [ Table 6 ] suggest that differentiation of osteoblasts may be compromised when infected with AB and PA in the first 72 hours of infection.
In bone biology, studies have revealed that Signal transducer and activator of transcription 1 (Stat1) is involved in osteoclastogenesis and osteoblast differentiation in addition to immune regulation [23] .
Previously, it was observed that osteoblast differentiation in vitro was significantly enhanced in the absence of Stat1 indicating that Stat1 interferes with osteoblast differentiation. Also, Stat1 acts as an attenuator of Runx2 in the cytoplasm [23] . Stat1 has been found to be a negative regulator associated with both bone formation and resorption and it maintains the homeostasis of the skeletal system. Our data indicates that when infected with AB, KP or PA, Stat1 was up-regulated at several time points, suggesting that osteoblast differentiation may be obstructed due to the activation of Stat1 during infection with AB, KP or PA.
Among growth factors involved in osteoblast differentiation, bone morphogenetic protein (BMP) family proteins play a crucial role in osteogenesis. BMPs are members of the transforming growth factor-13 (TGF-13) superfamily and regulate osteoblast function and development and are vital to this intercellular signaling system, and they activate osteoblast differentiation. Studies with recombinant BMP's 2, 4, 6, and 7 have shown that they are strong inducers of osteoblast differentiation. In addition, BMP-2 and BMP-7 induce the activation and expression of Runx2 [24] [25] [26] [27] . BMP-2 stimulates osteoblast differentiation and bone formation [27] [28] [29] [30] . We observed the induction of BMP-2 in only AB infected osteoblasts suggesting that it promoted proliferation and differentiation during infection with AB, and BMP-7 was induced in both AB and KP at different times. PA infection did not affect the expression of either gene [ Table 7 ].
Cell-cell adhesion by cadherins is essential for the function of bone forming cells during osteogenesis.
Also, cell adhesion is associated with other biological processes such as the immune response, wound healing and tissue structure maintenance. Osteoblasts express a limited number of cadherins, including the classic N-cadherin, CDH2. The expression profile of N-cadherin in osteoblasts during bone formation in vivo and in vitro suggests a role of this molecule in osteogenesis. Our data shows that both KP and PA induced CDH2 at 4 hours post-infection, but by 72 hours, it was down-regulated. When infected with AB, CDH2 was down-regulated at 48hours [ Table 8 ]. It has been found that interruption of cadherinmediated adhesion prevents induction of a fully differentiated osteoblastic phenotype [31] . We found that CDH4 was not significantly expressed to any of these pathogens except for the down-regulation at 24 hours after infection with KP.
When osteoblasts are activated, they produce pro inflammatory cytokines [32, 33] . Cultured osteoblasts, like cells in vitro, secrete cytokines such as IL-1 and IL-6 [34] [35] [36] . It has been found that IL-6 produced by osteoblasts may play a role in the activity of osteoclasts associated with bone resorption [37] [38] [39] .
Previous investigations on bacterial arthritis induced by S. aureus and S. agalactiae have suggested that TNFα, interleukin1β, and IL-6 are associated with pathogenesis of bacterial arthritis [40, 41] . TNFα is known to be involved in osteoclastogenesis and stimulate osteoclast formation and differentiation [42] .
Both IL1β and TNFα are thought to contribute directly to tissue damage by activation of osteoclasts which induce the release of tissue-damaging enzymes [43, 44] . In addition to stimulating resorption, it is known that IL1β and TNFα also inhibit bone formation in vitro [45] [46] [47] [48] [49] [50] . IL1β expression was induced by all three bacterial infections with early induction by AB and KP, while PA infection induced IL1β at all time points [ Table 8 ]. TNFα expression was also induced early for AB, and for KP at three time points. PA infection resulted in the up-regulation of TNFα at all time points [ Table 8 ]. Previously, Bost et al [51] demonstrated that cultured murine or human osteoblasts express high levels of IL-6 following exposure We detected the presence of IL-6 in the supernates of infected osteoblasts [ Fig 9] which was in agreement with the gene expression data [table 8 ]. The pro-inflammatory cytokine IL-6 was detected in smaller quantities [Fig 9] . We also detected large amounts of IL-8 in the supernates [Fig 9] . Interestingly, even though IL1β and TNFα genes were induced during infection, we did not detect secreted IL1β or TNFα proteins to any of the 3 pathogens in the supernates of infected osteoblasts.
Milestone 2: Therapy with antimicrobial peptides
The second stage of the proposed study was to evaluate the activity of antimicrobial peptides on infected osteoblasts and study the therapeutic activities of these peptides. We tested the bactericidal activity of a single peptide, KSL-W, against AB and KP in the 3-D osteoblast model as it was not effective against PA.
We found that Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa may survive intra-cellularly in osteoblasts. If antibiotics or other therapeutics are administered, it may result in survival of these pathogens intra-cellularly due to inadequate amounts of antibiotic or therapeutic that infiltrates osteoblasts.
A synthetic antimicrobial decapeptide KSL was identified [54] . KSL was reported to be a promising antimicrobial agent to be incorporated in chewing gum formulation as it prevented the development of oral biofilm and inhibit oral pathogens in vitro [55] [56] [57] . 
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Challenges in the research project
The main challenge to this work was working with primary osteoblasts. Work with primary osteoblasts is challenging as they grow very slow, and have limited ability to divide.
The proposed work was to test antimicrobial peptides to treat infected osteoblasts. The findings from this work suggest that all three species of bacteria can survive intra-cellularly in osteoblasts. The tested peptide KSL-W does not penetrate eukaryotic cell membranes, and future studies are needed to modify the peptide or encapsulate the peptide to reach the intracellular bacteria in osteoblasts. Post infection, the expression of several genes related to osteoblast differentiation, maturation and inflammation was investigated. Infection with AB resulted in osteoblast marker genes ALP and BGLAP being either reduced or expression unchanged, suggesting that osteoblast differentiation may not be optimal. Another important gene related to osteoblast differentiation, Dlx5, was either down-regulated or had no significant changes when infected with AB, KP or PA. The transcription factor Twist1 needs down-regulation for osteoblast differentiation, yet we saw up-regulation when infected with AB and PA, and no significant change with KP. Cell adhesion genes were also impacted by infection as N-cadherin (CDH2) was down-regulated or not significant at the later time points except for the initial up-regulation at 4 hours for KP and PA. Interestingly, the growth factor gene BMP2 was up-regulated only for AB, and BMP7 was up-regulated for AB and KP. Infection with PA did not result in significant changes to either BMP2 or 7.
The master transcription factor Runx2, which is the activator of osteoblast differentiation, was not significantly different from the uninfected controls for AB and KP and increasing for PA at 72 hours. As the expression of several other genes also may depend on Runx2, it could contribute to the lack of expression observed. Overall, our results suggest that even though osteoblasts harbor low numbers of these intracellular pathogens, it may result in a delay in osteoblast maturation and well-being at 3 days post infection. This is indicated by the differential expression of several genes associated with osteoblast maturation such as ALP, CDH2, TWIST1 and Stat1.The long term effects of such infections on the bone cells are unknown.
In addition, AB infection elicited an early inflammatory response with IL1β, IL-8, IL-6 and TNFα expression. KP infection was similar, except IL-8 and TNFα were induced at 48 and 72 hours post infection respectively. PA infection resulted in a more robust expression of these genes across the time points. The secreted IL-6 by osteoblasts suggests that IL-6 may contribute towards development of protective responses. IL-6 may also result in harmful effects on the bone such as inflammatory damage and bone resorption. The secretion of high levels of neutrophil attractant IL-8 suggests that neutrophils may also be important towards protective responses and clearing the infection. We found some differences in the expression of IL-6 and IL-8 gene expression secreted amounts detected. We believe that if our independent sample numbers were increased to at least 6 or more instead of 3, these differences can be minimized. It is recommended that for future work, sample size needs to be increased. These pro-inflammatory responses in osteoblasts suggest that intracellular infection with these bacteria does result in changes to the bone cells which may affect their differentiation and maturation processes.
Treatment of osteoblast infections with peptide KSL-W was tested. KSL-W was effective in decreasing the extracellular bacterial load in the media with scaffolds for both AB and KP. Intracellular bacteria were not reduced significantly by KSL-W treatment. As appropriate, it is recommended that therapies should be focused towards the eradication of both extra and intracellular bacteria. For example, cell penetrating peptides should be tested against these bacteria. An antimicrobial peptide formulation in nanoparticle encapsulation may be more appropriate for treatment of intracellular AB, KP and PA infections of the osteoblasts. 
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